Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Sees Large Growth in Short Interest

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPYGet Free Report) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 200 shares, an increase of 100.0% from the October 31st total of 100 shares. Based on an average trading volume of 600 shares, the days-to-cover ratio is currently 0.3 days.

Hikma Pharmaceuticals Stock Down 1.6 %

Shares of HKMPY traded down $0.84 during trading hours on Friday, hitting $50.64. The stock had a trading volume of 633 shares, compared to its average volume of 711. The company’s fifty day moving average is $49.45 and its two-hundred day moving average is $50.15. Hikma Pharmaceuticals has a 52 week low of $43.68 and a 52 week high of $55.56.

About Hikma Pharmaceuticals

(Get Free Report)

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

Featured Stories

Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.